Last reviewed · How we verify
NCT04004364: ESPRITO
Early-Phase Schizophrenia: Practice-based Research to Improve Outcomes
trial testing Coordinated Specialty Care (CSC) in First Episode Psychosis in 700 participants. Currently enrolling.
31 March 2025
Quick facts
| Lead sponsor | Northwell Health |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 700 |
| Start date | 1 April 2020 |
| Primary completion | 31 March 2025 |
| Estimated completion | 31 March 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Coordinated Specialty Care (CSC)
Conditions studied
- First Episode Psychosis — all drugs for First Episode Psychosis →
Sponsor
Northwell Health — full company profile →
Who can join
Adults 15 to 40, any sex, with First Episode Psychosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal if the project is to develop a learning health network devoted to the treatment of first episode psychosis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04004364
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Coordinated Specialty Care (CSC)
Trials testing the same drug.
- NCT04497857 — Academic-Community EPINET (AC-EPINET) · NA · completed
Other recruiting trials for First Episode Psychosis
Currently open trials in the same condition.
- NCT06774417 — Digital Strategies to Advance Help-Seeking - Aim 3 · NA · recruiting
- NCT06774430 — Digital Strategies to Advance Help-Seeking Aim 1 and 2 · recruiting
- NCT05310838 — Optimizing Engagement in Services for First-Episode Psychosis · NA · active not recruiting
- NCT04046497 — Artificial Intelligence to Measure Adherence to Oral Medication · Phase 4 · recruiting
- NCT04005378 — Disengagement in CSC: Identifying Those at Risk and Addressing Their Needs · Phase 4 · recruiting
Other Northwell Health trials
Trials by the same sponsor.
- NCT07253662 — Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Patients With Peritoneal Metastasis From Pancreatic Aden · Phase 1 · recruiting
- NCT07191041 — Emotional Urinary Tract Infection · not yet recruiting
- NCT07254091 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Pancreatic Cancer · EARLY_PHASE1 · recruiting
- NCT07344961 — Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB) · recruiting
- NCT07193862 — Pilot Study of an Implantable Microdevice for In Situ Evaluation of Drug Response in Patients With Colorectal Liver Meta · EARLY_PHASE1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04004364 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwell Health
- Last refreshed: 19 September 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04004364.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing